160 results on '"Zhou, Dun-hua"'
Search Results
2. Outcome and prognostic factors of CBF pediatric AML patients with t(8;21) differ from patients with inv(16)
3. Thalassaemia in China
4. Poor outcome of pediatric patients with acute myeloid leukemia harboring high FLT3/ITD allelic ratios
5. Pneumocystis jirovecii-associated immune reconstitution inflammatory syndrome-like phenomenon in a child with leukaemia: a case report and literature review
6. Prognostic value and outcome for acute lymphocytic leukemia in children with MLL rearrangement: a case-control study
7. Benefits of the Continuous Use of 6-MP/MTX with Pulses of VCR/DEX in Maintenance Therapy for Pediatric Acute Lymphoblastic Leukemia: A Report from South China Children's Leukemia Group
8. Effect of Low-Dose Recombinant Interleukin-2 Therapy on Immunocyte Subsets in Children with Solid Tumor.
9. DNA index as prognostic factor in childhood acute lymphoblastic leukemia in the COG-TARGET database
10. Coexistence of ETV6-RUNX1 and MLL aberration among pediatric acute lymphoblastic leukemia: case reports and a literature review
11. Clinical summary of pediatric acute lymphoblastic leukemia patients complicated with asparaginase-associated pancreatitis in SCCLG-ALL-2016 protocol.
12. Ruxolitinib inhibits the proliferation and induces the apoptosis of MLL-r ALL cells through inactivating JAK/STAT signaling pathway
13. An optimized UHPLC-MS/MS method for simultaneous determination of erythrocyte methotrexate and polyglutamylated metabolites: Application in pediatric patients with acute lymphoblastic leukemia
14. Chidamide as maintenance after chemotherapy or hematopoietic stem cell transplantation in 27 children with T-cell lymphoblastic leukemia: A real-world prospective study
15. Prognostic Scoring System for Pediatric Epstein-Barr Virus Infection-Associated Haemophagocytic Lymphohistiocytosis Based on Baseline Characteristics: A Multicentric Retrospective Study
16. TARGET Based m6A Methylation-Related Genes Predict Prognosis Relapsed B-Cell Acute Lymphoblastic Leukemia
17. Unconventional treatment for an unusual cauda equina syndrome associated with nontuberculous mycobacteria after allogenic stem cell transplantation in a child with acute lymphoblastic leukemia
18. Analysis of clinical characteristics and prognostic factors associated with EBV-associated HLH in children
19. Mutational landscape and clinical outcome of pediatric acute myeloid leukemia with 11q23/KMT2Arearrangements
20. Population Pharmacokinetics and Initial Dosage Optimization of Tacrolimus in Pediatric Hematopoietic Stem Cell Transplant Patients
21. Reassessment of the Risk-stratified GD-2008 ALL Protocol
22. Unconventional treatment for an unusual cauda equina syndrome associated with nontuberculous mycobacteria after allogenic stem cell transplantation in a child with acute lymphoblastic leukemia.
23. A Nomogram for Predicting Event-Free Survival in Childhood Acute Lymphoblastic Leukemia: A Multicenter Retrospective Study
24. Mutational landscape and clinical outcome of pediatric acute myeloid leukemia with 11q23/KMT2A rearrangements.
25. CEBPA are independent good prognostic factors in pediatric acute myeloid leukemia
26. Wilms Tumor 1 Mutations Are Independent Poor Prognostic Factors in Pediatric Acute Myeloid Leukemia
27. Rabbit-antithymocyte globulin combined with cyclosporin A as a first-line therapy: improved, effective, and safe for children with acquired severe aplastic anemia
28. Bone marrow mesenchymal stem cells reduce the antitumor activity of cytokine-induced killer/natural killer cells in K562 NOD/SCID mice
29. CEBPA are independent good prognostic factors in pediatric acute myeloid leukemia.
30. Re-Evaluate of DNA Index Among the Childhood Acute Lymphoblastic Leukemia
31. The Value of Alveolar Lavage Fluid mNGS in the Peripheral Pulmonary Among Children
32. Poor Outcome of Pediatric Patients with Acute Myeloid Leukemia Harbour High FLT3/ITD Allelic Ratios
33. Eltrombopag as first‐line treatment for thrombocytopenia among paediatric patients after allogeneic haematopoietic stem cell transplantation
34. Wilms Tumor 1 Mutations are Independent Poor Prognostic Factors in Pediatric Acute Myeloid Leukemia
35. Prediction, management, and prognosis of mixed chimerism after hematopoietic stem cell transplantation in transfusion‐dependent pediatric thalassemia patients
36. [Untitled]Changes of CD16 and CD11a expression in cytokine-induced killer cells/natural killer cells during cultivation
37. [Untitled]Changes of CD16 and CD11a expression in cytokine-induced killer cells/natural killer cells during cultivation
38. [Clinical Charcteristics and Prognostic Analysis of 28 cases of Pediatric Myelodysplastic Syndrome]
39. Eltrombopag as first‐line treatment for thrombocytopenia among paediatric patients after allogeneic haematopoietic stem cell transplantation.
40. The early diagnostic value of serum galactomannan antigen test combined with chest computed tomography for invasive pulmonary aspergillosis in pediatric patients after hematopoietic stem cell transplantation
41. Combination antifungal treatment for invasive fungal disease after hematopoietic stem cell transplantation in children with hematological disorders
42. Diagnosis and treatment of juvenile myelomonocytic leukemia
43. Severe hypertension is an independent risk factor for posterior reversible encephalopathy syndrome post-hematopoietic cell transplantation in children with thalassemia major
44. Modified conditioning regimen improves outcomes of unrelated donor peripheral blood stem cell transplantation for β-thalassaemia major patients.
45. X-linked Hyper-IgM Syndrome: A Phenotype of Crohn's Disease with Hemophagocytic Lymphohistiocytosis
46. Allogeneic hematopoietic stem cell transplantation for childhood aplastic anemia: prospective trial in China
47. Pre-Clinical Trial on the Co-Transplantation of MSCs and Umbilical Cord Blood Stem Cells
48. Relation of Treg and iNKT Cell Reconstruction with aGVHD after Allogenetic Hematopoietic Stem Cell Transplantation in Chidren.
49. Distribution and Interaction of Bone Marrow Mesenchymal Stem Cells and Cord Blood CIK/NK Cells Infused via Different Ways at Different Time Periods in NOD/SCID Mice.
50. Expansion of CIK/NK Cells from Cord Blood by Using Different Combinations of Stem Cell Factor, FLT3 Ligand and Interleukin 2, 7, 15 in vitro.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.